Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pacific Biosciences (DE:P09)
BERLIN:P09
Pacific Biosciences (P09) Stock Price & Analysis
1 Followers
P09 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€2.59 - €12.87
Previous Close€2.59
Volume0.00
Average Volume (3M)437.00
Market Cap
€714.74M
Enterprise Value€872.76M
Total Cash (Recent Filing)$767.79M
Total Debt (Recent Filing)$935.56M
Price to Earnings (P/E)-2.3
Beta2.43
Next Earnings
May 02, 2024EPS Estimate
-€0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.12
Shares Outstanding267,951,880
10 Day Avg. Volume41
30 Day Avg. Volume437
Standard Deviation0.20
R-Squared0.00248
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-3.90
Price to Sales (P/S)26.94
Price to Cash Flow (P/CF)-3.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.90
Enterprise Value/Gross Profit17.80
Enterprise Value/Ebitda-2.85
Forecast
1Y Price Target
€8.10Price Target Upside212.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Pacific Biosciences News
Options Prices
Currently, No data available
---
Ownership Overview
3.97% Insiders
25.87% Mutual Funds
27.63% Other Institutional Investors
42.53% Public Companies and
Individual Investors
P09 FAQ
What was Pacific Biosciences’s price range in the past 12 months?
Pacific Biosciences lowest stock price was €2.59 and its highest was €12.87 in the past 12 months.
What is Pacific Biosciences’s market cap?
Currently, no data Available
When is Pacific Biosciences’s upcoming earnings report date?
Pacific Biosciences’s upcoming earnings report date is May 02, 2024 which is in 6 days.
How were Pacific Biosciences’s earnings last quarter?
Pacific Biosciences released its earnings results on Feb 15, 2024. The company reported -€0.292 earnings per share for the quarter, missing the consensus estimate of -€0.27 by -€0.022.
Is Pacific Biosciences overvalued?
According to Wall Street analysts Pacific Biosciences’s price is currently Undervalued.
Does Pacific Biosciences pay dividends?
Pacific Biosciences does not currently pay dividends.
What is Pacific Biosciences’s EPS estimate?
Pacific Biosciences’s EPS estimate is -€0.26.
How many shares outstanding does Pacific Biosciences have?
Pacific Biosciences has 267,951,870 shares outstanding.
What happened to Pacific Biosciences’s price movement after its last earnings report?
Pacific Biosciences reported an EPS of -€0.292 in its last earnings report, missing expectations of -€0.27. Following the earnings report the stock price went down -2.168%.
Which hedge fund is a major shareholder of Pacific Biosciences?
Among the largest hedge funds holding Pacific Biosciences’s share is ARK Investment Management LLC. It holds Pacific Biosciences’s shares valued at 338M.
---
Pacific Biosciences Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€8.10 (212.76% Upside)
€8.10 (212.76% Upside)
Blogger Sentiment
Bullish
DE:P09 Sentiment 75%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $327.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-74.68%
12-Months-Change
Fundamentals
Return on Equity
-48.53%
Trailing 12-Months
Asset Growth
-1.19%
Trailing 12-Months
Company Description
Pacific Biosciences
Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
---
P09 Earnings Call
Q4 2024
0:00 / 0:00
---
P09 Stock 12 Months Forecast
Average Price Target
€8.10
▲(212.76% Upside)
Technical Analysis
Best Analysts Covering P09
1 Year
1 Year Success Rate
3/5 ratings generated profit
1 Year Average Return
+0.58%
reiterated a buy rating 2 months ago
Copying Ross Osborn's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +0.58% per trade.
---